5126 - 5150 of 6230 Results
Title
Year
-
OPENTitle: Motor and psychiatric features in idiopathic blepharospasm: A data-driven cluster analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 94End Page: 98Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11187571Citation Count: 10
-
OPENTitle: Atypical antipsychotic use and mortality risk in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 103Issue #:Start Page: 17End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.013Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11000674Citation Count: 7
- Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's disease2022OPENTitle: Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 57End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.009Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.06.009Citation Count: 8
- Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease2022OPENTitle: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 75End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013Best OA location URL: http://www.prd-journal.com/article/S1353802022002048/pdfCitation Count: 15
- Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine2022OPENTitle: Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 47End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.017Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.02.017Citation Count: 7
- Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activities2022OPENTitle: Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activitiesJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 184Issue #:Start Page: 106409End Page: 106409Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.phrs.2022.106409Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10074477Citation Count: 13
-
OPENTitle: Auto-annotating sleep stages based on polysomnographic dataJournal Name: PatternsPublisher: Elsevier BVVol: 3Issue #: 1Start Page: 100371End Page: 100371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.patter.2021.100371Best OA location URL: https://doi.org/10.1016/j.patter.2021.100371Citation Count: 23
- An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utility2022OPENTitle: An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utilityJournal Name: Seizure: European Journal of EpilepsyPublisher: Elsevier BVVol: 101Issue #:Start Page: 156End Page: 161Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.seizure.2022.08.003Best OA location URL: http://www.seizure-journal.com/article/S1059131122001820/pdfCitation Count: 7
- Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s disease2022OPENTitle: Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s diseaseJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 3Issue #: 2Start Page: 101445End Page: 101445Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xpro.2022.101445Best OA location URL: https://doi.org/10.1016/j.xpro.2022.101445Citation Count: 1
-
OPENTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.108998Citation Count: 4
-
OPENTitle: Anxiety in Parkinson's disease: A resting-state high density EEG studyJournal Name: Neurophysiologie CliniquePublisher: Elsevier BVVol: 52Issue #: 3Start Page: 202End Page: 211Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neucli.2022.01.001Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0987705322000016?via%3DihubCitation Count: 17
- Spontaneous changes in brain striatal dopamine synthesis and storage dynamics ex vivo reveal end-product feedback-inhibition of tyrosine hydroxylase2022OPENTitle: Spontaneous changes in brain striatal dopamine synthesis and storage dynamics ex vivo reveal end-product feedback-inhibition of tyrosine hydroxylaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 212Issue #:Start Page: 109058End Page: 109058Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109058Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109058Citation Count: 8
- Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model2022OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 8
-
OPENTitle: Preserved motor memory in Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 167Issue #:Start Page: 108161End Page: 108161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108161Best OA location URL: https://doi.org/10.1101/2021.04.30.441882Citation Count: 13
- Stimulation of the pedunculopontine and cuneiform nuclei for freezing of gait and falls in Parkinson disease: Cross-over single-blinded study and long-term follow-up2022OPENTitle: Stimulation of the pedunculopontine and cuneiform nuclei for freezing of gait and falls in Parkinson disease: Cross-over single-blinded study and long-term follow-upJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 13End Page: 17Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.010Best OA location URL: https://hal.sorbonne-universite.fr/hal-03603648v1/file/Bourilhon%20et%20al.%20-%202022%20-%20Stimulation%20of%20the%20pedunculopontine%20and%20cuneiform%20_organized.pdfCitation Count: 15
- Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies2022OPENTitle: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 65End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.022Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.01.022Citation Count: 18
- Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson's disease2022OPENTitle: Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 38End Page: 42Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.017Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.01.017Citation Count: 25
- Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variants2022OPENTitle: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 43End Page: 48Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021Best OA location URL: http://www.prd-journal.com/article/S1353802022002176/pdfCitation Count: 10
-
OPENTitle: Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasisJournal Name: Molecular CellPublisher: Elsevier BVVol: 82Issue #: 16Start Page: 3045End Page: 3060.e11Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2022.06.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9391305Citation Count: 45
-
OPENTitle: What the VaP? The meaning of “vascular parkinsonism”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 132End Page: 134Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.12.008Best OA location URL: http://www.prd-journal.com/article/S1353802021004636/pdfCitation Count: 7
- Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex2021OPENTitle: Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complexJournal Name: Molecular CellPublisher: Elsevier BVVol: 82Issue #: 1Start Page: 44End Page: 59.e6Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2021.11.012Best OA location URL: http://www.cell.com/article/S1097276521009916/pdfCitation Count: 82
-
OPENTitle: Racial disparities in hypertension management among multiple sclerosis patientsJournal Name: Multiple Sclerosis and Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 103972End Page: 103972Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.msard.2022.103972Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9308758Citation Count: 10
- White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia2021OPENTitle: White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementiaJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 111Issue #:Start Page: 54End Page: 63Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.11.007Citation Count: 47
- Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy2022OPENTitle: Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsyJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 34Issue #:Start Page: 103022End Page: 103022Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103022Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103022Citation Count: 27
- Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography2022OPENTitle: Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topographyJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 35Issue #:Start Page: 103080End Page: 103080Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103080Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103080Citation Count: 16